New You, Inc. (NWYU) Research

Based in Carlsbad, California, New You, Inc., operating via its subsidiary New You LLC, focuses on the development and commercialization of a diverse range of cannabidiol (CBD) hemp oil-based products. Their extensive portfolio encompasses liquid formulations such as "DROPS" for beverages, alongside advanced blends like "CB2 & CBD 2 Plus," which combines multi-spectrum hemp-extracted CBD with beta-caryophyllene. The company also provides "Drops for pets," an organic cannabinoid-infused non-GMO dark roast coffee named "Caffe Canna," and "ABSORB," a veggie capsule crafted from root and rice flour. Additional offerings include "RELEASE," "Drops FX" – a liquid blend of CBD with B vitamins (B3, B6, B9, and B12) – and "Drops FX Sleep," a unique combination of CBD, gamma-amino butyric acid, melatonin, and valerian root designed for restful sleep. Completing their product line are "NanoX," a water-soluble full-spectrum CBD prepared with purified water, and "The Cream," a topical skincare solution. New You, Inc. distributes its goods to independent business owners through both multi-level marketing channels and a direct sales force.

Market snapshot

Symbol
NWYU
Price
$0.00
Day change
0.00%
Market cap
$15.0K
P/E ratio
-0.00x
52-week range
2.0E-4-4.0E-4
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Acorda Therapeutics, Inc. (ACORQ)
  • Hempfusion Wellness Inc. (CBDHF)
  • Advanzeon Solutions, Inc. (CHCR)
  • Goodbody Health Limited (GDBYF)
  • Genesis Healthcare, Inc. (GENN)
  • MagForce AG (MGFRF)
  • Navidea Biopharmaceuticals, Inc. (NAVB)
  • NutraLife BioSciences, Inc. (NLBS)

Recent insider activity

  • Berry Jared — trade (0 shares) on 2020-02-05
  • Berry Jared — trade (0 shares) on 2020-02-05
  • Montoya Gregory Lee — trade (0 shares) on 2020-02-05
  • Sinkes James Patrick — trade (0 shares) on 2020-02-05
  • Ray Grimm Jr. — trade (0 shares) on 2020-02-05

Open New You, Inc. (NWYU) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.